Skip to main content

Find Clinical Trials

Home
Conditions
Macular Edema

Clinical trial condition

Macular Edema

Explore clinical trials studying Macular Edema. Study availability and eligibility vary by location and protocol.

150 public trials 8 recruiting studies

Refine in advanced search Browse all conditions

Macular Edema trial results

Completed

Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO

NCT02303184

Conditions: Cardiovascular Diseases, Embolism and Thrombosis, Eye Diseases, +8 more
Locations: Phoenix, Arizona, United States

Beverly Hills, California, United States

San Diego, California, United States

Boynton Beach, Florida, United States

View all 14 locations

View Trial Details

Completed

A Safety and Efficacy Study of Dexamethasone Versus Laser Photocoagulation in Participants With Diabetic Macular Edema

NCT02121262

Conditions: Eye Diseases, Macular Degeneration, Macular Edema, +2 more
Locations: Peking University First Hospital Beijing, Beijing Municipality, China

People's Hospital of Peking University Beijing, Beijing Municipality, China

Beijing Friendship Hospital of Capital Medical University Beijing, Beijing Municipality, China

Beijing Hospital Beijing, Beijing Municipality, China

View all 18 locations

View Trial Details

Completed

Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME)

NCT02818998

Conditions: Eye Diseases, Macular Degeneration, Macular Edema, +2 more
Locations: Graz, Styria, Austria

Vienna, Austria

Halifax, Nova Scotia, Canada

Mississauga, Ontario, Canada

View all 64 locations

View Trial Details

Completed

Retrospective Study of the Safety and Efficacy of Patients With RVO in Subjects Who Completed Parent Study CLS1003-201

NCT02956330

Conditions: Cardiovascular Diseases, Embolism and Thrombosis, Eye Diseases, +8 more
Locations: San Antonio, Texas, United States

View Trial Details

Completed

An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases.

NCT01908816

Conditions: Cardiovascular Diseases, Choroid Diseases, Choroidal Neovascularization, +19 more
Locations: Novartis Investigative Site Bobigny, Seine Saint Denis, France

Novartis Investigative Site Amiens, France

Novartis Investigative Site Angers, France

Novartis Investigative Site Bordeaux, France

View all 39 locations

View Trial Details

Completed

A Study to Evaluate THR-317 and Ranibizumab Combination Treatment for Diabetic Macular Oedema (DME)

NCT03499223

Conditions: Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +12 more
Locations: CHU Brugmann Brussels, Belgium

UZ Leuven Leuven, Belgium

Centre Rétine Gallien Bordeaux, France

Centre Hospitalier Intercommunal de Créteil Créteil, France

View all 37 locations

View Trial Details

Completed

Study to Evaluate Home Vision Testing in Participants Who Receive Ranibizumab (Lucentis®)

NCT02420132

Conditions: Eye Diseases, Macular Degeneration, Macular Edema, +2 more
Locations: Rocky Mountain Retina Salt Lake City, Utah, United States

View Trial Details

Completed

Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema

NCT01476449

Conditions: Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +9 more
Locations: Retina Vitreous Associates of Florida Clearwater, Florida, United States

Retina Vitreous Associates of Florida St. Petersburg, Florida, United States

View Trial Details

Completed

Intravitreal Aflibercept Injection for Radiation Retinopathy

NCT01579760

Conditions: Eye Diseases, Macular Degeneration, Macular Edema, +3 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

Retina Consultants of Houston Houston, Texas, United States

View Trial Details

Completed

A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion

NCT00168324

Conditions: Cardiovascular Diseases, Embolism and Thrombosis, Eye Diseases, +8 more
Locations: Los Angeles, California, United States

Sydney, Australia

Graz, Austria

Halifax, Nova Scotia, Canada

View all 13 locations

View Trial Details